Literature DB >> 18601196

Mechanism of insulin aggregation and stabilization in agitated aqueous solutions.

V Sluzky1, A M Klibanov, R Langer.   

Abstract

Undesirable aggregation of aqueous insulin solutions remains a serious obstacle in the development of alternative methods of diabetes therapy. We investigated the fundamental nature of the aggregation mechanism and proposed stabilization strategies based on a mathematical model for the reaction scheme. Insulin aggregation kinetics in the presence of solid-liquid and air-liquid interfaces were monitored using UV spectroscopy and quasielastic light scattering (QELS). Experimental observations were consistent with our model of monomer denaturation at hydrophobic surfaces followed by the formation of stable intermediate species which facilitated subsequent macroaggregation. The model was used to predict qualitative trends in insulin aggregation behavior, to propose stabilization strategies, and to elucidate mechanisms of stabilization. In the absence of additives, insulin solutions aggregated completely (more than 95% of the soluble protein lost) within 24 h; with sugar-based nonionic detergents, no detectable loss occurred for more than 6 weeks. (c) 1992 John Wiley & Sons, Inc.

Entities:  

Year:  1992        PMID: 18601196     DOI: 10.1002/bit.260400805

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  31 in total

1.  Inverse relationship of protein concentration and aggregation.

Authors:  Michael J Treuheit; Andrew A Kosky; David N Brems
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.

Authors:  Miles A Miller; Layla Barkal; Karen Jeng; Andreas Herrlich; Marcia Moss; Linda G Griffith; Douglas A Lauffenburger
Journal:  Integr Biol (Camb)       Date:  2010-12-23       Impact factor: 2.192

3.  Displacement of adsorbed insulin by Tween 80 monitored using total internal reflection fluorescence and ellipsometry.

Authors:  S H Mollmann; U Elofsson; J T Bukrinsky; S Frokjaer
Journal:  Pharm Res       Date:  2005-08-16       Impact factor: 4.200

4.  Intrinsic fibrillation of fast-acting insulin analogs.

Authors:  R Jeremy Woods; Javier Alarcón; Elaine McVey; Ronald J Pettis
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

5.  Effects of environmental factors on MSP21-25 aggregation indicate the roles of hydrophobic and electrostatic interactions in the aggregation process.

Authors:  Xuecheng Zhang; Yuanqiu Dong; Jigang Yu; Xiaoming Tu
Journal:  Eur Biophys J       Date:  2013-10-23       Impact factor: 1.733

6.  Storage stability of keratinocyte growth factor-2 in lyophilized formulations: effects of formulation physical properties and protein fraction at the solid-air interface.

Authors:  Dilip Devineni; Christoph Gonschorek; Marcus T Cicerone; Yemin Xu; John F Carpenter; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2014-05-21       Impact factor: 5.571

7.  Trehalose Glycopolymer Enhances Both Solution Stability and Pharmacokinetics of a Therapeutic Protein.

Authors:  Yang Liu; Juneyoung Lee; Kathryn M Mansfield; Jeong Hoon Ko; Sahar Sallam; Chrys Wesdemiotis; Heather D Maynard
Journal:  Bioconjug Chem       Date:  2017-01-03       Impact factor: 4.774

8.  Long-term and high-temperature storage of supercritically-processed microparticulate protein powders.

Authors:  M A Winters; P G Debenedetti; J Carey; H G Sparks; S U Sane; T M Przybycien
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

9.  Controlling the aggregation and rate of release in order to improve insulin formulation: molecular dynamics study of full-length insulin amyloid oligomer models.

Authors:  Workalemahu Mikre Berhanu; Artëm E Masunov
Journal:  J Mol Model       Date:  2011-06-15       Impact factor: 1.810

10.  The molecular chaperone alpha-crystallin as an excipient in an insulin formulation.

Authors:  Tue Rasmussen; Ruedeeporn Tantipolphan; Marco van de Weert; Wim Jiskoot
Journal:  Pharm Res       Date:  2010-03-24       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.